The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples

Clinical Microbiology and Infection

Volumn 16, Issue 11, 2010, Pages 1656-1658

  Rogers, G B ^a   Marsh, P ^b   Stressmann, A F ^a   Allen, C E ^b   Daniels, T V W ^c   Carroll, M P ^c   Bruce, K D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antibiotic treatment; Bacterial viability; Cystic fibrosis; Propidium monoazide; Q PCR

Indexed keywords

BACTERIAL DNA; PROPIDIUM IODIDE; PROPIDIUM MONOAZIDE; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL CELL; BACTERIUM DETECTION; CONTROLLED STUDY; CYSTIC FIBROSIS; FALSE POSITIVE RESULT; HUMAN; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 77955266472     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03189.x     Document Type: Article

References (16)

1. Panousis K, Grigoris P, Butcher I, Rana B, Reilly JH, Hamblen DL. Poor predictive value of broad-range PCR for the detection of arthroplasty infection in 92 cases. Acta Orthop 2005; 76: 341-346.
2. Josephson KL, Gerba CP, Pepper IL. Polymerase chain reaction detection of nonintact bacterial pathogens. Appl Environ Microbiol 1993; 59: 3513-3515.
3. Young G, Turner S, Davies JK, Sundqvist G, Figdor D. Bacterial DNA persists for extended periods after cell death. J Endod 2007; 33: 1417-1420.
4. Castillo M, Martin-Orue SM, Manzanilla EG, Badiola I, Martin M, Gasa J. Quantification of total bacteria, enterobacteria and lactobacilli populations in pig digesta by real-time PCR. Vet Microbiol 2006; 114: 165-170.
5. Nocker A, Sossa KE, Camper AK. Molecular monitoring of disinfection efficacy using propidium monoazide in combination with quantitative PCR. J Microbiol Methods 2007; 70: 252-260.
6. Nocker A, Sossa-Fernandez P, Burr MD, Camper AK. Use of propidium monoazide for live/dead distinction in microbial ecology. Appl Environ Microbiol 2007; 73: 5111-5117.
7. Rogers GB, Stressmann FA, Koller G, Daniels T, Carroll MP, Bruce KD. Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections. Diagn Microbiol Infect Dis 2008; 62: 133-141.
8. Kobayashi H, Oethinger M, Tuohy MJ, Hall GS, Bauer TW. Improving clinical significance of PCR: use of propidium monoazide to distinguish viable from dead Staphylococcus aureus and Staphylococcus epidermidis. J Orthop Res 2009; 27: 1243-1247.
9. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Bruce KD. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 2004; 42: 5176-5183.
10. Shannon KE, Lee DY, Trevors JT, Beaudette LA. Application of real-time quantitative PCR for the detection of selected bacterial pathogens during municipal wastewater treatment. Sci Total Environ 2007; 382: 121-129.
11. Robinson M, Bye PT. Mucociliary clearance in cystic fibrosis. Pediatr Pulmonol 2002; 33: 293-306.
12. Alenius H, Pakarinen J, Saris O et al. Contrasting immunological effects of two disparate dusts-preliminary observations. Int Arch Allergy Immunol 2009; 149: 81-90.
13. Zhang T, Fang HH. Applications of real-time polymerase chain reaction for quantification of microorganisms in environmental samples. Appl Microbiol Biotechnol 2006; 70: 281-289.
14. Deschaght P, De Baere T, Van Simaey L et al. Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. BMC Microbiol 2009; 9: 244-250.
15. Rogers GB, Carroll MP, Serisier DJ et al. Bacterial activity in cystic fibrosis lung infections. Respir Res 2005; 6: 49-60.
16. Kobayashi H, Oethinger M, Tuohy MJ, Procop GW, Hall GS, Bauer TW. Limiting false-positive polymerase chain reaction results: detection of DNA and mRNA to differentiate viable from dead bacteria. Diagn Microbiol Infect Dis 2009; 64: 445-447.